Global Reach BIOSYNEX operates in France and over 90 countries, presenting an opportunity to expand international distribution partnerships, channel sales, and localization strategies for rapid diagnostics and consumer health brands.

Diagnostic Leadership As a leading rapid diagnostics group with a broad product portfolio, there is potential to upsell complementary tests, expand OEM/white-label collaborations, and cross-sell to PTS Diagnostics, Chembio, and related networks through strategic partnerships.

Wellness Portfolio Beyond diagnostics, BIOSYNEX owns wellness brands like INNOXA and PARAKITO; this opens sales plays in preventive care, eye and dermo-cosmetics, and anti-nuisible solutions to complementary consumer-health retailers and e-commerce channels.

Growth Momentum Past expansions and headcount increases amid rising demand indicate scale-up potential; explore enterprise-grade solutions, manufacturing partnerships, and supply-chain collaborations to support growing distribution and production needs.

Digital & Data With tech stack covering Salesforce, Shopify, WordPress, and data tools, there are opportunities to propose integrated sales enablement, e-commerce optimization, and data-driven marketing collaborations to accelerate go-to-market and customer engagement.